Northern Trust Corp lowered its position in shares of Agilent Technologies, Inc. (NYSE:A) by 1.9% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,599,202 shares of the medical research company’s stock after selling 70,223 shares during the period. Northern Trust Corp owned 1.12% of Agilent Technologies worth $213,468,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. UBS Asset Management Americas Inc. grew its position in Agilent Technologies by 9.8% during the first quarter. UBS Asset Management Americas Inc. now owns 882,075 shares of the medical research company’s stock worth $46,635,000 after buying an additional 78,851 shares in the last quarter. Greenwood Capital Associates LLC acquired a new stake in Agilent Technologies during the first quarter worth approximately $215,000. Pacer Advisors Inc. grew its position in Agilent Technologies by 3.3% during the first quarter. Pacer Advisors Inc. now owns 6,430 shares of the medical research company’s stock worth $340,000 after buying an additional 205 shares in the last quarter. Aberdeen Asset Management PLC UK grew its position in Agilent Technologies by 1.4% during the first quarter. Aberdeen Asset Management PLC UK now owns 194,215 shares of the medical research company’s stock worth $10,268,000 after buying an additional 2,716 shares in the last quarter. Finally, Chesapeake Asset Management LLC acquired a new stake in Agilent Technologies during the first quarter worth approximately $902,000.

A has been the topic of a number of analyst reports. BidaskClub downgraded Agilent Technologies from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, June 13th. Deutsche Bank AG reissued a “buy” rating and set a $66.00 price target on shares of Agilent Technologies in a research report on Thursday, June 22nd. Morgan Stanley reissued an “overweight” rating on shares of Agilent Technologies in a research report on Monday, July 10th. Wells Fargo & Company raised Agilent Technologies from a “market perform” rating to an “outperform” rating and increased their price target for the stock from $42.92 to $60.73 in a research report on Wednesday, July 12th. Finally, Barclays PLC reissued a “buy” rating and set a $67.00 price target on shares of Agilent Technologies in a research report on Wednesday, July 19th. Three analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Agilent Technologies presently has an average rating of “Buy” and an average price target of $63.91.

Shares of Agilent Technologies, Inc. (A) opened at 65.78 on Friday. The firm has a market cap of $21.17 billion, a P/E ratio of 33.92 and a beta of 1.30. The firm has a 50 day moving average price of $62.75 and a 200-day moving average price of $58.31. Agilent Technologies, Inc. has a one year low of $42.92 and a one year high of $66.45.

Agilent Technologies (NYSE:A) last announced its earnings results on Tuesday, August 15th. The medical research company reported $0.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.52 by $0.07. Agilent Technologies had a net margin of 14.36% and a return on equity of 16.95%. The company had revenue of $1.11 billion during the quarter, compared to analyst estimates of $1.09 billion. During the same period in the previous year, the business earned $0.49 earnings per share. The firm’s quarterly revenue was up 6.7% compared to the same quarter last year. Analysts forecast that Agilent Technologies, Inc. will post $2.32 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 25th. Shareholders of record on Tuesday, October 3rd will be given a dividend of $0.132 per share. The ex-dividend date is Monday, October 2nd. This represents a $0.53 annualized dividend and a yield of 0.80%. Agilent Technologies’s payout ratio is 27.32%.

WARNING: “Northern Trust Corp Sells 70,223 Shares of Agilent Technologies, Inc. (A)” was reported by Watch List News and is owned by of Watch List News. If you are reading this piece of content on another site, it was copied illegally and republished in violation of US & international trademark & copyright law. The correct version of this piece of content can be viewed at https://www.watchlistnews.com/northern-trust-corp-sells-70223-shares-of-agilent-technologies-inc-a/1584983.html.

In related news, insider Dominique Grau sold 13,007 shares of the stock in a transaction dated Wednesday, August 16th. The shares were sold at an average price of $62.00, for a total value of $806,434.00. Following the completion of the transaction, the insider now directly owns 60,098 shares of the company’s stock, valued at $3,726,076. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Patrick Kaltenbach sold 5,000 shares of the stock in a transaction dated Thursday, July 13th. The stock was sold at an average price of $61.26, for a total transaction of $306,300.00. Following the completion of the transaction, the insider now directly owns 45,138 shares of the company’s stock, valued at $2,765,153.88. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 170,720 shares of company stock valued at $10,795,039.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.